All BioScience Global Ferravitin products are backed by rigorous clinical trials and human cellular studies. They demonstrate significant, and rapid, improvement in iron restoration at low dosage with no side effects.
"Effect of Ferravitin on Iron Deficient Women 28 y/o - 46 y/o"
Duration: 30 days
Ferravitin Dose: 6 mg/day PVP, 20mg/day iron
Day 0 Iron Level: 20.3 ng/mL
Day 30 Iron Level: 52.7 ng/mL
% Improvement: 159%
Side Effects: None
"Effect of Ferravitin on Iron Deficient Women 22 y/o – 53 y/o”
Ferravitin Dose: 6 mg/day PVP, 20mg/day iron
Duration: 30 days
Day 0 Iron Level: 18.6 ng/mL
Day 30 Iron Level: 47.8 ng/mL
% Improvement: 157%
Side Effects: None
“Comparison of Iron Absorption in Human Caco-2* cell line: Ferravitin v. Iron”
Control: 0
Ferritin Increase with iron: 1.59
Day 0 Iron Level: 18.6 ng/mL
Ferritin Increase with Ferravitin: 13.2
% Improvement: 837%
*Derived from human intestinal epithelial cells
A new study shows that nearly 1 in 3 adults in the United States are deficient in iron. Screening for iron deficiency is not routine, which makes it difficult to understand its prevalence. Iron deficiency is linked to poorer brain health, insomnia, heart failure, and other health concerns.